Article
Molecular analysis of an HBsAg-negative hepatitis B virus mutant selected in a tenofovir-treated HIV-hepatitis B virus co-infected patient.
AIDS (London, England) - 14 Jan 2009
Amini-Bavil-Olyaee Samad, Sheldon Julie, Lutz Thomas, Trautwein Christian, Tacke Frank
Abstract excerpt
The molecular analysis performed in an HIV-hepatitis B virus (HBV) coinfected patient revealed selection of an unusual HBV polymerase mutation (rtV191I) during tenofovir-containing therapy, conferring simultaneously immune escape by HBsAg negativity and resistance to lamivudine but not tenofovir. Phenotypic analysis revealed impaired replicative capacity of mutants, which could be restored by concomitant precore...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
